Your browser does not support JavaScript
Has your mesothelioma NOT responded to treatment or gotten worse after treatment?

You may be eligible for the INFINITE clinical research study.

Malignant pleural mesothelioma (MPM) tumors can be difficult to treat. Some tumors don’t respond to treatment at all, or do respond, but then come back. Currently, there are no approved treatment options for MPM once the first line of treatment has failed.

The INFINITE clinical research study is looking at the safety and effectiveness of an investigational agent (rAd-IFN), when given with celecoxib and gemcitabine, on slowing or stopping growth in these types of tumors.



Copyright © 2022 | INFINITE Study | All Rights Reserved | Privacy | Terms & Conditions